Table 2 Study assessments

Coping with itch and disease

JUCKKI-COPECI (8-12 yr) or JUCKJU-COPEJU (13-18 yr) [23]

x

x

x

x

x

Disease-specific quality of life

CDQLI [31]

x

x

x

x

x

Disease activity and control (AD)

EASI [33]

x

x

x

x

x

SA-EASI [25]

x

x

x

x

x

Used topical corticosteroids

x

x

x

x

x

TARC [34]

x

x

x

x

x

Disease activity and control (Asthma)

ACQ [35]

x

x

x

x

x

PAQLQ [36]

x

x

Lung function test

x

x

x

x

x

FeNO

x

x

x

x

x

Used medication

x

x

x

x

x

Metacholine provocation

x

x

x

x

x

Serum

Total IgE

x

x

Specific IgE: inhalation/food: ImmunoCAP

x

x

Specific IgE: inhalation/food: ImmunoCAP ISAC

x

Eosinophils

x

x

x

x

Cytokine profile

x

x

x

x

Questionnaires

Social demographic information

x

Intelligence test [37]

x

SF-36 [38, 39]

x

CBCL [40, 41]

x

Corticosteroid use

x

x

x

NPV-J [42]

x

TRF [40]

x

CBSK/CBSA [43, 44]

x

x

x

ZBV-K [45]

x

x

x

x

PUL (>12 yr) [46]

x

x

x

Quality of life (parents) [47]

x

x

x

x

ZBV [48]

x

x

x

NOSI-K [49]

x

x

x

NOSI-events [49]

x

x

Other

Maximal cycle ergometer test

x

x

Bacterial colonization of the skin

x

x

x

x

Bacterial colonization of the nose

x

x

x

x

Skin strips for protease activity

x

x

x

x